{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:23Z","timestamp":1792784123907,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Jubilaeumsfonds of The Oesterreichische Nationalbank","award":["16888"],"award-info":[{"award-number":["16888"]}],"id":[{"id":"https:\/\/ror.org\/00nkcmy90","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11307-019-01413-7","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:02:31Z","timestamp":1564491751000},"page":"739-744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Whole-Body [18F]FDG-PET\/MRI vs. [18F]FDG-PET\/CT in Malignant Melanoma"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-8500","authenticated-orcid":false,"given":"Dominik","family":"Berzaczy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Staudenherz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundula","family":"Berzaczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius E.","family":"Mayerhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"1413_CR1","doi-asserted-by":"publisher","first-page":"647684","DOI":"10.1155\/2012\/647684","volume":"2012","author":"F Tas","year":"2012","unstructured":"Tas F (2012) Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors. J Oncol 2012:647684","journal-title":"J Oncol"},{"key":"1413_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"F Meier","year":"2002","unstructured":"Meier F, Will S, Ellwanger U et al (2002) Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 147:62\u201370","journal-title":"Br J Dermatol"},{"key":"1413_CR3","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","volume":"25","author":"JE Gershenwald","year":"2018","unstructured":"Gershenwald JE, Scolyer RA (2018) Ann Surg Oncol 25:2105","journal-title":"Ann Surg Oncol"},{"key":"1413_CR4","first-page":"1","volume":"11","author":"A Pflugfelder","year":"2013","unstructured":"Pflugfelder A, Kochs C, Blum A et al (2013) Malignant melanoma S3-guideline \u201cdiagnosis, therapy and follow-up of melanoma\u201d. J Dtsch Dermatol Ges 11:1\u2013116","journal-title":"J Dtsch Dermatol Ges"},{"key":"1413_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-017-3691-7","volume":"44","author":"ANM Wong","year":"2017","unstructured":"Wong ANM, McArthur GA, Hofman MS, Hicks RJ (2017) The advantages and challenges of using FDG PET\/CT for response assessment in melanoma in the era of targeted agents and immunotherapy. Eur J Nucl Med Mol Imaging 44:67\u201377","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1413_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET\/CT: EANM procedure guidelines for tumor imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1413_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00259-014-2885-5","volume":"42","author":"P Heusch","year":"2015","unstructured":"Heusch P, Nensa F, Schaarschmidt B et al (2015) Diagnostic accuracy of whole-body PET\/MRI and whole-body PET\/CT for TNM staging in oncology. Eur J Nucl Med Mol Imaging 42:42\u201348","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1413_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/RLI.0000000000000218","volume":"5","author":"C Giraudo","year":"2016","unstructured":"Giraudo C, Raderer M, Karanikas G et al (2016) 18F-Fluorodeoxyglucose positron emission tomography\/magnetic resonance in lymphoma: comparison with 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and with the addition of magnetic resonance diffusion-weighted imaging. Invest Radiol 5:163\u2013169","journal-title":"Invest Radiol"},{"key":"1413_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/RLU.0000000000001753","volume":"42","author":"D Berzaczy","year":"2017","unstructured":"Berzaczy D, Giraudo C, Haug AR et al (2017) Whole-body 68Ga-DOTANOC PET\/MRI Versus68Ga-DOTANOC PET\/CT in patients with neuroendocrine tumors: a prospective study in 28 patients. Clin Nucl Med 42:669\u2013674","journal-title":"Clin Nucl Med"},{"key":"1413_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13139-013-0240-6","volume":"48","author":"JH Jeong","year":"2014","unstructured":"Jeong JH, Cho IH, Kong EJ et al (2014) Evaluation of Dixon sequence on hybrid PET\/MR compared with contrast-enhanced PET\/CT for PET-positive lesions. Nucl Med Mol Imaging 48:26\u201332","journal-title":"Nucl Med Mol Imaging"},{"key":"1413_CR11","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1097\/RLU.0000000000001461","volume":"42","author":"T Sekine","year":"2017","unstructured":"Sekine T, Barbosa FG, Sah BR et al (2017) PET\/MR outperforms PET\/CT in suspected occult tumors. Clin Nucl Med 42:e88\u2013e95","journal-title":"Clin Nucl Med"},{"key":"1413_CR12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/RLU.0000000000001344","volume":"42","author":"A Afaq","year":"2017","unstructured":"Afaq A, Fraioli F, Sidhu H et al (2017) Comparison of PET\/MRI with PET\/CT in the evaluation of disease status in lymphoma. Clin Nucl Med 42:e1\u2013e7","journal-title":"Clin Nucl Med"},{"key":"1413_CR13","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s00259-013-2467-y","volume":"40","author":"M Souvatzoglou","year":"2013","unstructured":"Souvatzoglou M, Eiber M, Takei T et al (2013) Comparison of integrated whole-body [11C]choline PET\/MR with PET\/CT in patients with prostate cancer. Eur J Nucl Med Mol Imaging 40:1486\u20131499","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1413_CR14","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1007\/s00330-016-4255-0","volume":"26","author":"SM Lee","year":"2016","unstructured":"Lee SM, Goo JM, Park CM et al (2016) Preoperative staging of non-small cell lung cancer: prospective comparison of PET\/MR and PET\/CT. Eur Radiol 26:3850\u20133857","journal-title":"Eur Radiol"},{"key":"1413_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2967\/jnumed.113.129247","volume":"55","author":"I Rauscher","year":"2014","unstructured":"Rauscher I, Eiber M, F\u00fcrst S et al (2014) PET\/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET\/CT. J Nucl Med 55:724\u2013729","journal-title":"J Nucl Med"},{"key":"1413_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ejrad.2010.03.004","volume":"79","author":"V Kulemann","year":"2011","unstructured":"Kulemann V, Schima W, Tamandl D et al (2011) Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 79:e1\u2013e6","journal-title":"Eur J Radiol"},{"key":"1413_CR17","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1007\/s00330-013-2785-2","volume":"23","author":"ME Mayerhoefer","year":"2013","unstructured":"Mayerhoefer ME, Ba-Salamah A, Weber M et al (2013) Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET\/MRI in patients with neuroendocrine tumors of the upper abdomen. Eur Radiol 23:1978\u20131985","journal-title":"Eur Radiol"},{"key":"1413_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiol.2016151155","volume":"281","author":"AN Melsaether","year":"2016","unstructured":"Melsaether AN, Raad RA, Pujara AC et al (2016) Comparison of whole-body (18)F FDG PET\/MR imaging and whole-body 18F FDG PET\/CT in terms of lesion detection and radiation dose in patients with breast cancer. Radiology 281:193\u2013202","journal-title":"Radiology"},{"key":"1413_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2967\/jnumed.113.123646","volume":"55","author":"M Eiber","year":"2014","unstructured":"Eiber M, Takei T, Souvatzoglou M et al (2014) Performance of whole-body integrated 18F-FDG PET\/MR in comparison to PET\/CT for evaluation of malignant bone lesions. J Nucl Med 55:191\u2013197","journal-title":"J Nucl Med"},{"key":"1413_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11307-017-1105-7","volume":"20","author":"AM Muehe","year":"2018","unstructured":"Muehe AM, Theruvath AJ, Lai L, Aghighi M, Quon A, Holdsworth SJ, Wang J, Luna-Fineman S, Marina N, Advani R, Rosenberg J, Daldrup-Link HE (2018) How to provide gadolinium-free PET\/MR cancer staging of children and young adults in less than 1\u00a0h: the Stanford Approach. Mol Imaging Biol 20:324\u2013335","journal-title":"Mol Imaging Biol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01413-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-019-01413-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01413-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T19:23:15Z","timestamp":1595964195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-019-01413-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1413"],"URL":"https:\/\/doi.org\/10.1007\/s11307-019-01413-7","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"30 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"MEM has received speaker honoraria and research support from Siemens Healthineers, as well as speaker honoraria from Bristol-Myers Squibb.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}